Clinical Trial Update: Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Utidelone in third-line and above treatment of small cell lung cancer (extensive stage) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: SCLC, Extensive Stage | Phase 2 | Status: UNKNOWN